Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Magdalena Erlebach
,
Ruediger Lange
Added:
3 years ago
Patients with multivalvular disease (MVD) can present with a variety of valve pathologies and combinations, often requiring a complex treatment strategy. Both the Euro Heart Survey and the EURObservational Research Programme Valvular Heart Disease Registry (presented at the European Society of Cardiology [ESC] 2018 meeting) demonstrated that more than one-fifth of patients with native valve…
View more
Puja Kachroo
Research Area(s) / Expertise:
Job title: Cardiac Surgeon & Co-Director at the Washington University Aortic Center & Co-Director of the Valve Center
Author
Multi Vessel Disease in STEMI
Author(s):
Pim Tonino
,
Jacques Monsegu
Start date:
Jun 17, 2020
Broadcast
Author(s):
Satinder K Sandhu
Added:
3 years ago
Over the last three decades numerous transcatheter therapies for the treatment of congenital heart disease (CHD) have been developed.
Interatrial Septal Defect
Balloon atrial septostomy has been performed in patients with transposition physiology and in patients where egress of blood is needed from the left or the right atrium and in adults with pulmonary vascular disease where the creation of…
View more
Author(s):
Nicolas M Van Mieghem
Start date:
Dec 08, 2016
An interactive live case collaboration between the Thoraxcenter, Erasmus MC and Interventional Cardiology Review.
View more
Author(s):
Pascal Thériault-Lauzier
,
Marco Spaziano
,
Beatriz Vaquerizo
,
et al
Added:
3 years ago
Valvular Disease
Aortic valve
Severe symptomatic aortic stenosis (AS) bears a dismal prognosis. The mean survival is 2.0 to 4.7 years after the onset of angina, 0.8 to 3.8 years after the onset of syncope and 0.5 to 2.8 years after the onset of congestive heart failure.1 Surgical aortic valve replacement (SAVR) is the mainstay of treatment for these patients.2 In the last decade transcatheter…
View more
Author(s):
Marco Valgimigli
,
Vijay Kunadian
,
Pascal Vranckx
,
et al
Start date:
Feb 22, 2023
View more
Author(s):
Marco Valgimigli
,
Eliano Navarese
,
Pascal Vranckx
Added:
1 year ago
This three-part programme delves into the critical importance of individualised antithrombotic treatment in both Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS).
Part one of this programme presents two compelling patient case studies.Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective…
View more
Author(s):
Abhiram Prasad
Added:
8 years ago
Professor Abhiram Prasad discusses 'New Stents' with Radcliffe Cardiology.
This video interview was conducted at the ‘Advances in the Pathogenesis and Management of Cardiovascular Disease’ meeting held at the Royal College of Surgeons in London, UK on the 27th November 2015.
View more